Global Medical Isotope Shortages Highlight Supply Chain Vulnerabilities
2024-03-15
Recent disruptions in the supply chain for critical medical isotopes like Molybdenum-99 (precursor to Technetium-99m) and Iodine-131 have underscored the fragility of global production, often reliant on a few aging research reactors. These isotopes, with their specific short half-lives, cannot be stockpiled indefinitely, making continuous, reliable production essential for diagnostic imaging and cancer therapy. India's efforts to enhance indigenous production capabilities are crucial for national health security.
UPSC Angle: Impact of half-life on medical isotope logistics, national self-reliance in nuclear medicine, challenges in nuclear reactor maintenance, and international cooperation in nuclear technology [VY:SCI-06-03-02].